Exabis Library
Welcome to the e-CCO Library!
P619: Incidence of collagenous colitis in NHS Lothian:  a population-based study
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P619: Inflammatory bowel disease meets fertility: a physicians and patients survey
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P619: Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P619: Patterns of Anti-TNF Prescribing & Therapy Outcome in a Large Multicentre Cohort of Inflammatory Bowel Disease Patients
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P619: Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P619: Tofacitinib for the treatment of resistant ulcerative colitis: the University of Chicago experience
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P620 Maintenance of clinical remission with SB5 biosimilar after switch from adalimumab originator: Real-life experience of a tertiary referral centre 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P620: Can ustekinumab trough and antidrug antibody levels post induction predict treatment failure?
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P620: Differences in illness perceptions of Inflammatory Bowel Disease (IBD) between Healthcare Practitioners (HCPs) and patients in a UK tertiary IBD centre.
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM
P620: Golimumab in ulcerative colitis: A multi-centre real-world experience
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P620: Network meta-analysis of efficacy and safety of different intravenous iron compounds for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P620: Pivoting in a pandemic: The impact of COVID-19 on the provision of care for patients with Inflammatory Bowel Disease – A retrospective study
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P620: Stapled end-to-side vs. side-to-side anastomosis after ileocecectomy for Crohn’s disease: a propensity score-matched analysis 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P621 Physician preferences for biologics (originator vs. biosimilar) for the treatment of ulcerative colitis in France, Germany and the UK 
 2020
ECCO'20 Vienna
 Thursday, 30 January 2020, 10:12 AM
P621: Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study
 2023
 ECCO’23 Copenhagen
 Friday, 14 July 2023, 11:05 AM
P621: Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
 2017
 ECCO '17 Barcelona
 Wednesday, 20 February 2019, 10:36 AM
P621: Faecal calprotectin after the induction of anti-TNF therapy predicts mucosal healing in patients with ulcerative colitis: A prospective single-centre study
 2018
 ECCO '18 Vienna
 Thursday, 21 February 2019, 9:14 AM
P621: Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease
 2021
 ECCO'21 Virtual
 Wednesday, 2 June 2021, 4:12 PM
P621: Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study 
 2019
ECCO '19 Copenhagen
 Friday, 22 February 2019, 9:41 AM
P621: Secure Electronic Document Signing Uptake in Biologic Prescribing for Immune Mediate Diseases
 2022
 ECCO'22
 Friday, 11 February 2022, 3:56 PM